Review: taking Serevent and Albuterol sulfate together


Summary

Drug interactions are reported among people who take Serevent and Albuterol sulfate together. This review analyzes the effectiveness and drug interactions between Serevent and Albuterol sulfate. It is created by eHealthMe based on reports of 1,241 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Serevent and Albuterol sulfate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Serevent

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. (latest outcomes from Serevent 12,659 users)

Albuterol Sulfate

Albuterol sulfate has active ingredients of albuterol sulfate. It is often used in asthma. (latest outcomes from Albuterol sulfate 10,239 users)

On Aug, 27, 2016

1,241 people who take Serevent, Albuterol Sulfate are studied.


Number of reports submitted per year:

Serevent and Albuterol sulfate drug interactions.

Drug effectiveness over time:

Serevent:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Albuterol Sulfate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Serevent:
  • female: 50.0% - (1 of 2 people)
  • male: 66.0% - (2 of 3 people)
Albuterol Sulfate:
  • female: 100.0% - (2 of 2 people)
  • male: 66.0% - (2 of 3 people)

Drug effectiveness by age:

Serevent:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Albuterol Sulfate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • drug ineffective
  • oesophagitis
  • oropharyngeal candidiasis
  • pneumonia
  • wheezing
  • throat irritation
  • adverse reaction
  • dyspnoea
  • heart rate increased
  • adverse event
1 - 6 months:
  • drug ineffective
  • asthma
  • throat irritation
  • vocal cord disorder
  • angina unstable
  • blister
  • dyspnoea
  • mouth ulceration
  • asthenia
  • chest pain
6 - 12 months:
  • dyspnoea
  • consciousness fluctuating
  • drug ineffective
  • hyperhidrosis
  • loss of dreaming
  • pregnancy - vaginal bleeding
  • sleeplessness
  • urine iron increased
  • acute coronary syndrome
  • acute pulmonary oedema
1 - 2 years:
  • asthma
  • dyspnoea
  • sudden death
  • acute coronary syndrome
  • atelectasis
  • bronchitis
  • bronchitis acute
  • chronic obstructive pulmonary disease
  • collapse of lung
  • drug ineffective
2 - 5 years:
  • asthma
  • abdominal distension
  • hyperkalaemia
  • pyrexia
  • status asthmaticus
  • abdominal tenderness
  • cyanosis
  • disability
  • dyspnoea
  • gastric perforation
5 - 10 years:
  • asthma
  • cardio-respiratory arrest
  • depressed level of consciousness
  • hyporeflexia
  • bronchitis
  • dyspnoea
  • insomnia
  • pneumonia
  • productive cough
  • sinusitis
10+ years:
  • heart rate increased
  • back pain
  • dizziness
  • dyspnoea
  • coma
  • lung neoplasm
  • rectal haemorrhage
  • sudden death
  • asthma
  • device failure
not specified:
  • asthma aggravated
  • drug ineffective
  • asthma
  • chest pain
  • dyspnoea
  • nausea
  • pyrexia
  • fatigue
  • cough
  • pneumonia

Most common drug interactions by gender *:

female:
  • drug ineffective
  • asthma aggravated
  • asthma
  • chest pain
  • dyspnoea
  • nausea
  • pyrexia
  • fatigue
  • cough
  • anxiety
male:
  • asthma
  • asthma aggravated
  • drug ineffective
  • pneumonia
  • dyspnoea
  • hypoaesthesia
  • asthenia
  • weight increased
  • erectile dysfunction
  • chest pain

Most common drug interactions by age *:

0-1:
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood creatine phosphokinase increased
  • blood creatinine increased
  • blood lactic acid increased
  • blood pressure increased
  • bronchopulmonary dysplasia
  • complications of maternal exposure to therapeutic drugs
  • cytomegalovirus infection
  • emphysema
2-9:
  • anaphylactic reaction
  • hemiplegia
  • cerebellar infarction
  • collapse
  • disorientation
  • gasping
  • growth retarded
10-19:
  • asthma aggravated
  • collapse of lung
  • chest tightness
  • aggression
  • drug effect decreased
  • drug ineffective
  • drug maladministration
  • chest pain
  • allergy aggravated
  • collapse
20-29:
  • asthma
  • asthma aggravated
  • dyspnoea
  • cardio-respiratory arrest
  • depressed level of consciousness
  • hyporeflexia
  • bronchitis
  • sinusitis
  • cardiac arrest
  • pneumonia
30-39:
  • weight increased
  • asthma aggravated
  • epidural lipomatosis
  • hypoaesthesia
  • asthenia
  • urinary incontinence
  • cushingoid
  • erectile dysfunction
  • hyperreflexia
  • sensory disturbance
40-49:
  • chest pain
  • asthma aggravated
  • pyrexia
  • drug ineffective
  • arthralgia
  • myalgia
  • chest tightness
  • asthma
  • cough
  • fatigue
50-59:
  • asthma aggravated
  • drug ineffective
  • asthma
  • fatigue
  • chest pain
  • pyrexia
  • respiratory distress
  • dyspnoea
  • nausea
  • cough
60+:
  • drug ineffective
  • dyspnoea
  • asthma aggravated
  • asthma
  • pneumonia
  • cough
  • chest pain
  • heart rate increased
  • anxiety
  • back pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Serevent and Albuterol sulfate?

Can you answer these questions?

More questions for: Serevent, Albuterol sulfate

You may be interested in these reviews

More reviews for: Serevent, Albuterol sulfate

On eHealthMe, Serevent (salmeterol xinafoate) is often used to treat asthma. Albuterol sulfate (albuterol sulfate) is often used to treat asthma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.